tiprankstipranks
Trending News
More News >
Gyre Therapeutics (GYRE)
NASDAQ:GYRE
US Market

Gyre Therapeutics (GYRE) Ratios

Compare
803 Followers

Gyre Therapeutics Ratios

GYRE's free cash flow for Q4 2024 was $0.96. For the 2024 fiscal year, GYRE's free cash flow was decreased by $ and operating cash flow was $0.02. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.32 2.85 1.68 3.63 5.03
Quick Ratio
2.99 2.64 1.31 3.23 5.03
Cash Ratio
0.61 1.67 1.29 3.13 1.71
Solvency Ratio
0.45 -2.41 0.07 -6.01 -2.95
Operating Cash Flow Ratio
-0.19 1.29 -1.97 -5.91 -3.09
Short-Term Operating Cash Flow Coverage
-5.11 0.00 0.00 -42.36 -83.03
Net Current Asset Value
$ 37.78M$ 19.16M$ -21.93M$ 36.90M$ 70.73M
Leverage Ratios
Debt-to-Assets Ratio
0.01 <0.01 <0.01 0.04 0.02
Debt-to-Equity Ratio
0.03 -0.03 >-0.01 0.06 0.02
Debt-to-Capital Ratio
0.02 -0.03 >-0.01 0.05 0.02
Long-Term Debt-to-Capital Ratio
0.01 0.00 0.00 0.00 0.01
Financial Leverage Ratio
1.98 -7.36 -1.31 1.35 1.25
Debt Service Coverage Ratio
15.21 0.00 13.92 -44.29 -85.48
Interest Coverage Ratio
0.00 0.00 -12.01- 0.00
Debt to Market Cap
<0.01 0.00 0.00 <0.01 <0.01
Interest Debt Per Share
0.02 <0.01 <0.01 0.08 0.09
Net Debt to EBITDA
-0.63 -1.63 -2.09 0.48 0.50
Profitability Margins
Gross Profit Margin
96.33%95.91%-0.50%-0.57%56.26%
EBIT Margin
15.35%16.94%1159.07%-1198.32%-268.48%
EBITDA Margin
15.28%17.92%1301.26%-1193.84%-273.87%
Operating Profit Margin
15.28%-59.26%-1084.51%-1197.79%-273.87%
Pretax Profit Margin
21.95%-67.84%-994.21%-1198.32%-268.48%
Net Profit Margin
11.43%-81.92%289.92%-1198.32%-265.14%
Continuous Operations Profit Margin
16.92%-75.35%543.32%-1198.32%-265.14%
Net Income Per EBT
52.05%120.75%-29.16%100.00%98.76%
EBT Per EBIT
143.65%114.48%91.67%100.04%98.03%
Return on Assets (ROA)
9.64%-79.74%8.09%-157.98%-58.56%
Return on Equity (ROE)
19.09%587.14%-10.61%-214.01%-73.02%
Return on Capital Employed (ROCE)
15.26%-69.67%-74.10%-211.81%-74.46%
Return on Invested Capital (ROIC)
11.69%-77.21%-74.23%-199.85%-72.91%
Return on Tangible Assets
9.66%-80.92%8.18%-251.97%-58.56%
Earnings Yield
1.17%-5.93%0.38%-21.02%-3.06%
Efficiency Ratios
Receivables Turnover
5.40 6.74 0.05 4.04 6.32
Payables Turnover
35.96 13.06 6.54 1.15 1.54
Inventory Turnover
0.61 1.08 0.13 1.29 9.16K
Fixed Asset Turnover
4.12 4.77 11.34 1.98 9.25
Asset Turnover
0.84 0.97 0.03 0.13 0.22
Working Capital Turnover Ratio
2.57 4.67 0.03 0.13 0.30
Cash Conversion Cycle
652.98 363.28 10.62K 55.84 -178.49
Days of Sales Outstanding
67.61 54.18 7.88K 90.43 57.73
Days of Inventory Outstanding
595.52 337.05 2.80K 282.88 0.04
Days of Payables Outstanding
10.15 27.95 55.80 317.47 236.26
Operating Cycle
663.13 391.23 10.68K 373.31 57.77
Cash Flow Ratios
Operating Cash Flow Per Share
-0.04 0.39 -0.43 -2.73 -2.87
Free Cash Flow Per Share
-0.07 0.26 -0.50 -2.76 -2.88
CapEx Per Share
0.03 0.13 0.07 0.03 0.01
Free Cash Flow to Operating Cash Flow
1.64 0.67 1.15 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
-1.57 3.02 -0.66 -99.83 -206.17
Capital Expenditure Coverage Ratio
-1.57 3.02 -6.62 -99.83 -206.17
Operating Cash Flow Coverage Ratio
-2.28 63.31 -870.95 -35.12 -33.48
Operating Cash Flow to Sales Ratio
-0.03 0.23 -41.68 -11.41 -2.63
Free Cash Flow Yield
-0.58%1.11%-6.24%-20.23%-3.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
85.20 -16.85 265.01 -4.76 -32.68
Price-to-Sales (P/S) Ratio
9.74 13.80 768.33 57.00 86.66
Price-to-Book (P/B) Ratio
16.26 -98.95 -28.13 10.18 23.86
Price-to-Free Cash Flow (P/FCF) Ratio
-172.88 90.50 -16.01 -4.94 -32.82
Price-to-Operating Cash Flow Ratio
-282.79 60.49 -18.43 -4.99 -32.98
Price-to-Earnings Growth (PEG) Ratio
-0.69 <0.01 -2.62 4.60 0.95
Price-to-Fair Value
16.26 -98.95 -28.13 10.18 23.86
Enterprise Value Multiple
63.07 75.42 56.95 -4.30 -31.14
EV to EBITDA
63.07 75.42 56.95 -4.30 -31.14
EV to Sales
9.64 13.51 741.09 51.28 85.29
EV to Free Cash Flow
-171.16 88.58 -15.45 -4.45 -32.30
EV to Operating Cash Flow
-279.99 59.21 -17.78 -4.49 -32.46
Tangible Book Value Per Share
1.15 1.17 -0.29 0.66 3.97
Shareholders’ Equity Per Share
0.74 -0.24 -0.28 1.34 3.97
Tax and Other Ratios
Effective Tax Rate
0.23 -0.11 -0.04 <0.01 0.01
Revenue Per Share
1.24 1.72 0.01 0.24 1.09
Net Income Per Share
0.14 -1.41 0.03 -2.87 -2.90
Tax Burden
0.52 1.21 -0.29 1.00 0.99
Interest Burden
1.43 -4.01 -0.86 1.00 1.00
Research & Development to Revenue
0.11 0.12 16.42 9.39 2.53
SG&A to Revenue
0.15 0.13 21.87 2.58 0.77
Stock-Based Compensation to Revenue
<0.01 0.06 16.83 -0.04 0.17
Income Quality
-0.20 -0.30 4.02 0.95 0.98
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis